Holen Sie sich die Stockscreener-App
23.52
0.55%
-0.13
Handel nachbörslich:
23.52
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt FMS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$23.65
Offen:
$23.7
24-Stunden-Volumen:
292.60K
Relative Volume:
0.94
Marktkapitalisierung:
$14.48B
Einnahmen:
$20.87B
Nettoeinkommen (Verlust:
$715.14M
KGV:
19.26
EPS:
1.2209
Netto-Cashflow:
$1.67B
1W Leistung:
-4.66%
1M Leistung:
-3.05%
6M Leistung:
+11.95%
1J Leistung:
+20.37%
1-Tages-Spanne:
$23.27
$23.70
1-Wochen-Bereich:
$23.27
$25.16
52-Wochen-Spanne:
$17.93
$25.96
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Firmenname
Fresenius Medical Care Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie FMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
23.52 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
HCA
Hca Healthcare Inc
|
317.61 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
DVA
Davita Inc
|
133.50 | 11.70B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
157.05 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
|
THC
Tenet Healthcare Corp
|
110.41 | 10.88B | 20.97B | 3.13B | 2.39B | 31.21 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Eingeleitet | Berenberg | Buy |
| 2024-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Hochstufung | Societe Generale | Hold → Buy |
| 2023-08-14 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Fortgesetzt | Citigroup | Neutral |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-03-07 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-03 | Herabstufung | Jefferies | Buy → Underperform |
| 2022-10-26 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-27 | Hochstufung | Jefferies | Underperform → Buy |
| 2022-02-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-11-23 | Eingeleitet | HSBC Securities | Hold |
| 2021-11-11 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-20 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Hochstufung | Jefferies | Hold → Buy |
| 2019-06-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Hochstufung | UBS | Neutral → Buy |
| 2018-08-28 | Hochstufung | HSBC Securities | Hold → Buy |
| 2018-07-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Hochstufung | UBS | Sell → Neutral |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-07-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2016-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Hochstufung | Goldman | Neutral → Buy |
| 2015-08-13 | Herabstufung | Societe Generale | Buy → Hold |
| 2015-07-31 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Bestätigt | Feltl & Co. | Hold |
| 2013-01-14 | Hochstufung | HSBC Securities | Neutral → Overweight |
Alle ansehen
Fresenius Medical Care Ag Adr Aktie (FMS) Neueste Nachrichten
From Kidney Failure to Fresenius Medical Care Employee: A Transplant Story - Fresenius Medical Care
Dialysis Nurse Becomes Kidney Patient After COVID-19 - Fresenius Medical Care
What Sets Our Nurses Apart - Fresenius Medical Care
A Transplant Story: Patient Care Technician Gives Dialysis Patient the Gift of Life - Fresenius Medical Care
Fresenius Medical Care plans bond sale stabilization By Investing.com - Investing.com South Africa
The Zacks Analyst Blog Highlights Reddit, Ubiquiti And Fresenius Medical Care AG - Barchart.com
Fresenius Medical Care plans bond sale stabilization - Investing.com
Predicting Population Trends in Kidney Health Using Advanced Mathematical Modeling - Fresenius Medical Care
Dry Bicarbonate Concentrate Bags for Hemodialysis in the State of São Paulo in Brazil - Fresenius Medical Care
Fresenius Economic Profit Margins Should Rise Along With Improvement in Both Operating Segments - Morningstar
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum - Fresenius Medical Care
Kidney Disease: Evolving the Standard of Care - Fresenius Medical Care
Sanctuary Advisors LLC Acquires New Holdings in Fresenius Medical Care AG (NYSE:FMS) - MarketBeat
Fresenius Medical Care ADR earnings missed by $0.26, revenue fell short of estimates - Investing.com South Africa
Fresenius Medical Care published form 20-F for the fiscal year 2024 - Fresenius Medical Care
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Earnings call transcript: Fresenius Medical Care sees strong Q4 2024 growth - Investing.com
Fresenius Medical Care Q4 earnings miss estimates, stock edges higher - Investing.com
Dialysis firm FMC beats profit estimates in fourth quarter By Reuters - Investing.com
Annual Press Conference 2025 - Fresenius Medical Care
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 - Fresenius Medical Care
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - Fresenius Medical Care
Growing Stronger Together: Embracing Diversity - Fresenius Medical Care
Corporate Citizenship - Fresenius Medical Care
Fresenius Medical Care: A 'Buy' Going Into 2025 (NYSE:FMS) - Seeking Alpha
Virtual reality as the next step in patient empowerment - Fresenius Medical Care
Coming Back Home: Dr. Len Usvyat Appointed as the Next Head of the Renal Research Institute - Fresenius Medical Care
17,962 miles halfway around the world - Fresenius Medical Care
“How can we improve and speed up medical decisions?” - Fresenius Medical Care
20 years creating a future worth living - Fresenius Medical Care
Overcoming challenges and seizing opportunities - Fresenius Medical Care
When Maria struck — One year after the hurricane - Fresenius Medical Care
Our Way Forward - Fresenius Medical Care
Corporate Movie 2021 - Fresenius Medical Care
Our way forward - Fresenius Medical Care
The Next Level of Renal Care - Fresenius Medical Care
Me and my four kidneys - Fresenius Medical Care
A superhero wins over Asia-Pacific - Fresenius Medical Care
Joining forces for a better future - Fresenius Medical Care
Improving dialysis through knowledge sharing in Southeast Asia - Fresenius Medical Care
A truly miraculous story – 50 years on dialysis - Fresenius Medical Care
Smart Companion for an active lifestyle - Fresenius Medical Care
The future is purple - Fresenius Medical Care
Regenerative Medicine: The road to healing - Fresenius Medical Care
The Life Long Learner - Fresenius Medical Care
Africa changing times - Fresenius Medical Care
A journey of friendship: How home hemodialysis changed Annalese's life - Fresenius Medical Care
Health Equity in Kidney Care: Interview with Lorien Dalrymple, MD, MPH - Fresenius Medical Care
20 years Fresenius Medical Care - Fresenius Medical Care
Making transplants safer and more widely available - Fresenius Medical Care
Remuneration of the Supervisory Board - Fresenius Medical Care
Finanzdaten der Fresenius Medical Care Ag Adr-Aktie (FMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):